Innospec Inc. — FY 2021 Form 10-K
Reporting period: Fiscal year ended December 31, 2021. This is an annual filing, not a standalone fourth-quarter report. Innospec develops and sells specialty chemicals across Fuel Specialties, Performance Chemicals and Oilfield Services. Octane Additives ceased trading in 2020.
Financial performance
| Metric | 2021 | 2020 | Change |
|---|---|---|---|
| Net sales | $1,483.4 million | $1,193.1 million | +24% |
| Gross profit / margin | $434.9 million / 29.3% | $342.7 million / 28.7% | +27%; margin +0.6 percentage points |
| Operating income | $132.1 million | $33.7 million | +292% |
| Income before tax | $134.4 million | $39.7 million | +239% |
| Net income / diluted EPS | $93.1 million / $3.75 | $28.7 million / $1.16 | Net income more than tripled |
| Cash from operations | $93.2 million | $145.9 million | Down $52.7 million |
| Capital expenditures | $39.1 million | $29.7 million | Up $9.4 million |
Operating cash flow less capital expenditures was approximately $54.1 million in 2021, versus $116.2 million in 2020. Management attributed the lower operating cash flow principally to working-capital growth as activity recovered.
Segment trends
- Fuel Specialties: Sales $618.3 million, up 21%; operating income $104.6 million, up from $84.5 million. Gross margin was 31.2%, slightly lower year over year as higher raw-material costs took time to pass through.
- Performance Chemicals: Sales $525.3 million, up 23%; operating income $70.9 million, versus $54.8 million. Growth was led by Americas personal-care demand and improved pricing/product mix; gross margin eased 0.6 percentage points to 23.8%.
- Oilfield Services: Sales $339.8 million, up 33%; operating income recovered to $10.4 million from a $9.5 million loss. Gross margin improved to 34.3% from 31.7%, though exploration-product demand remained below management’s expectations.
Liquidity, debt and balance sheet
- Cash and cash equivalents were $141.8 million at year-end, up from $105.3 million. The $250 million revolving credit facility, extended to September 2024, had no borrowings outstanding; finance-lease debt was $0.1 million.
- Current assets were $728.1 million and current liabilities $336.6 million; working capital was $391.5 million. Adjusted working capital, a company-defined non-GAAP measure, was $264.9 million, up $37.1 million.
- Inventory increased $57.6 million and receivables increased $63.1 million, reflecting higher activity and inventory built partly in anticipation of 2022 demand and supply disruption.
- Total assets were $1,570.9 million and equity $1,033.0 million. Plant-closure provisions were $56.5 million, principally for remediation and asset retirement obligations at Ellesmere Port, U.K.
- The company paid $28.8 million in dividends in 2021 ($1.16 per share). A $50 million share-repurchase program was announced February 15, 2022, after year-end.
Changes, outlook and risks
- 2021 was a broad recovery from pandemic-affected 2020: all three continuing businesses grew sales. However, consolidated revenue remained below 2019’s $1,513.3 million and net income below 2019’s $112.2 million.
- Operating income benefited from the absence of 2020’s $21.3 million restructuring charge and $19.8 million intangible-asset impairment; 2021 included a $1.8 million gain on disposal of assets.
- The effective tax rate rose to 30.7% from 27.7%. Revaluation of U.K. deferred tax liabilities following the enacted U.K. tax-rate increase added $7.3 million to tax expense. Management’s adjusted effective tax rate was 22.7% (non-GAAP).
- Management expected tight supply chains and elevated inflation to persist into 2022, while expressing cautious optimism that these conditions would moderate. It anticipated continued growth across businesses, further Oilfield Services operating leverage and margin expansion, and Fuel Specialties margin recovery as inflation moderated.
- Capital priorities include a $70 million Performance Chemicals growth-investment plan, potential complementary acquisitions, dividends and the newly announced repurchase authorization. Management also planned continued R&D investment.
- Principal risks include COVID-19 and economic uncertainty; raw-material, energy and logistics costs and availability; oil-and-gas activity and prices; competition and technology shifts; foreign exchange; regulatory and environmental obligations; cybersecurity; and the potential long-term displacement of leaded aviation gasoline. The filing reports no material pending legal proceedings.
- Auditors issued unqualified opinions on the financial statements and internal controls. Plant-closure provisions were identified as a critical audit matter because estimates of remediation scope, timing, cost and discount rates require significant judgment.
Key facts for investors to verify
- Whether sales recovery converts into sustained operating-margin and cash-flow improvement, particularly as working capital and capital investment remain elevated.
- How quickly raw-material inflation and supply constraints moderate, and whether price increases continue to offset cost pressure.
- Oilfield Services demand, operating leverage and margins relative to management’s 2022 expectations.
- The assumptions and future cash requirements behind the $56.5 million plant-closure provision, and sensitivity of the U.K. pension position to discount-rate and inflation assumptions.
- Execution and funding of the $70 million Performance Chemicals investment plan and the timing and use of the $50 million repurchase authorization.
- The reported-to-adjusted tax-rate reconciliation, including the U.K. rate revaluation and outstanding tax reviews.